For research use only. Not for therapeutic Use.
Proglumide (Cat.No:I012288) is a drug that acts as a cholecystokinin receptor antagonist. It is primarily used in research settings to study the physiological and pharmacological effects of cholecystokinin (CCK) and its receptors. Proglumide has also been investigated for its potential therapeutic applications in gastrointestinal disorders and as an adjunct in the treatment of certain types of cancer.
| Catalog Number | I012288 |
| CAS Number | 6620-60-6 |
| Synonyms | Milid; Gastrotopic; 4-Benzamido-5-(dipropylamino)-5-oxopentanoic acid |
| Molecular Formula | C18-H26-N2-O4 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| IUPAC Name | 4-benzamido-5-(dipropylamino)-5-oxopentanoic acid |
| InChI | 1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22) |
| InChIKey | DGMKFQYCZXERLX-UHFFFAOYSA-N |
| SMILES | C([C@@H](NC(c1ccccc1)<wbr>=O)<wbr>CCC(O)<wbr>=O)<wbr>(N(CCC)<wbr>CCC)<wbr>=O |
